AVIVAGEN INC (VIV.CA) Stock News
TSX-V:VIV - TSX Venture Exchange - CA05382F2026 - Common Stock - Currency: CAD
VIV.CA Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - Avivagen Inc.
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2023
Mentions: TSX
2 years ago - Avivagen Inc.
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth
Mentions: TSX
4 years ago - Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Resumption - VIV
4 years ago - Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
IIROC Trading Halt - VIV
4 years ago - TMX Group Limited
TMX Group, Avivagen, C-Suite at The Open
5 years ago - AVIVAGEN
AVIVAGEN to Present at The LD 500 Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:40 PM PST/9:40 AM EST. Kym Anthony, Chief Executive Officer will be presenting to a live audience. Register here: